Cargando…
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
The terminology used in pharmacovigilance can cause confusion, because there are similar terms that describe different phenomena (e.g. adverse reactions, adverse drug reactions, and side effects). Incorrect use of terminology can have negative effects on the reporting of adverse drug reactions and o...
Autores principales: | Baldo, Paolo, Francescon, Sara, Fornasier, Giulia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132975/ https://www.ncbi.nlm.nih.gov/pubmed/30094557 http://dx.doi.org/10.1007/s11096-018-0711-z |
Ejemplares similares
-
An historical overview over Pharmacovigilance
por: Fornasier, Giulia, et al.
Publicado: (2018) -
EU pharmacovigilance regulatory requirements of anticancer biosimilar monoclonal antibodies
por: Francescon, Sara, et al.
Publicado: (2018) -
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
por: Francescon, Sara, et al.
Publicado: (2016) -
Pharmacovigilance in oncology
por: Baldo, Paolo, et al.
Publicado: (2018) -
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
por: Fornasier, G., et al.
Publicado: (2018)